Recall Register

Food, drugs, devices › Angiodynamics Inc. (Navilyst Medical Inc.)

Device recall: Xcela PICC with PASV Valve Technology/Kit 5 F-55cm; (Maximum Flow Rate 3.5 mL/Sec)-indicated for short or long-term peri

FDA enforcement event 88596 · Class II · initiated 17 Oct 2017 · status Terminated · terminated 14 Jun 2022

DeviceVoluntary: Firm initiated1 product recordGlens Falls, NY

FDA enforcement event 88596 is a device recall by Angiodynamics Inc. (Navilyst Medical Inc.) of Glens Falls, NY, initiated 17 Oct 2017 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 1,091 device enforcement events initiated in 2017 carry the same class.

Status: Terminated, terminated 14 Jun 2022. Initiation: voluntary: firm initiated. Angiodynamics Inc. (Navilyst Medical Inc.) has 15 enforcement events on this register, with a median of 2 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Angiodynamics Inc. (Navilyst Medical Inc.), Glens Falls, NY.

Reason for recall

"Mislabeled: The product is labeled as 5F (55cm; Maximum Flow Rate 3.5 mL/Sec) and the product is actually 4F (55cm; Maximum Flow Rate 3.5 mL/Sec)."

Distribution

"Canada"

Product records

Recall numberProductQuantityClassStatusReport date
Z-2617-2021Xcela PICC with PASV Valve Technology/Kit 5 F-55cm; (Maximum Flow Rate 3.5 mL/Sec)-indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, and nutrients; the sampling of blood; and for power…4 boxes (5/each)= 20 eachesClass IITerminated6 Oct 2021

Context

93%of 2017 device events are Class II1,091 events that year
1product record in this eventfirm median: 2
15events on this register for the firm

Other enforcement events for Angiodynamics Inc. (Navilyst Medical Inc.)

InitiatedProduct (first record)TypeClassRecords
22 Feb 2021Smart Port CT-Implantable Port Catalogue #: CT96STSD-VI, CT96STSA-VI - Product Usage: indicated for any patient requirinDeviceClass II2
2 Oct 2019Starburst Talon Semi-Flex Electrosurgical Device, Part Number H7877001028451 incorrectly labelled as Starburst MRI Semi-DeviceClass II1
18 Sep 2019BIOFLO 8F SINGLE PLASTIC FILLED; NON-VALVED, UPN H965440140, Cat. No. 44-014 - Product Usage: Long-term access to the ceDeviceClass II5
17 Apr 2019AngioDynamics Solero Microwave Tissue Ablation (MTA) System: Solero Generator PG (1) Catalog Number:12740000 UPN: H78712DeviceClass II5
16 Oct 2018Xcela Power Injectable PICC with PASV (XCELA PASV 4F SL 55CM Catheter Kit CE PG), Cat no. 55-711DeviceClass II2
24 Jul 2018BioFlo Port with ENDEXO and PASV Technology-AngioDynamics BIOFLO 8F SINGLE PLASTIC NON-FILLED; VALVED PG UPN: H965440210DeviceClass II1
10 May 2018XCELA PASV 5F SL 55CM IR-145 Nitinol Wire KIT PG, Catalog Number 25-124DeviceClass II38
18 Jan 2018Fluid Management Convenience Kits (Angioplasty Kits) intended to be used in Fluid Management and/or Invasive Pressure MoDeviceClass II1
13 Jan 2017NAMIC Fluid Delivery Set - 72" (183cm) UPN H965913000051, Catalog 91300005DeviceClass II1
28 Nov 2016Xcela PICC Kit with ENDEXO and PASV Valve Technology, XCELA PASV 5F DL 55CM MST-70 Nitinol KIT PG, UPN H965251250, CatalDeviceClass II13

All 15 events for Angiodynamics Inc. (Navilyst Medical Inc.)

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Mislabeled: The product is labeled as 5F (55cm; Maximum Flow Rate 3.5 mL/Sec) and the product is actually 4F (55cm; Maximum Flow Rate 3.5 mL/Sec)."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Canada"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 14 Jun 2022. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.